Skip to main content
. 2009 Nov 19;17(3):812–820. doi: 10.1245/s10434-009-0827-4

Fig. 4.

Fig. 4

Cancer-specific survival by CRM in three categories: CRMs with tumor ingrowth (0 mm) had similar outcome to CRMs ≤1 mm and >0 mm (P = 0.43); both had significantly worse outcome compared with CRM >1 mm (P < 0.001 and P = 0.004, respectively)